Healthcare provider profile · identity verified

Danielle Herbst, APRN

Nurse Practitioner · MISSOULA, MT · NPI 1285238873

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	540	140
Omeprazole	Omeprazole	394	106
Levothyroxine Sodium	Levothyroxine Sodium	385	90
Losartan Potassium	Losartan Potassium	374	95
Amlodipine Besylate	Amlodipine Besylate	287	80
Simvastatin	Simvastatin	233	53
Lisinopril	Lisinopril	222	61
Hydrochlorothiazide	Hydrochlorothiazide	196	49
Metformin Hcl	Metformin Hcl	193	47
Trazodone Hcl	Trazodone Hcl	135	39
Famotidine	Famotidine	133	24
Metoprolol Succinate	Metoprolol Succinate	133	35
Gabapentin	Gabapentin	127	33
Pantoprazole Sodium	Pantoprazole Sodium	113	28
Potassium Chloride	Potassium Chloride	111	32
Tamsulosin Hcl	Tamsulosin Hcl	109	26
Mirtazapine	Mirtazapine	105	23
Furosemide	Furosemide	95	23
Tramadol Hcl	Tramadol Hcl	94	21
Sertraline Hcl	Sertraline Hcl	93	23
Duloxetine Hcl	Duloxetine Hcl	89	23
Montelukast Sodium	Montelukast Sodium	85	21
Glipizide	Glipizide	75	18
Metformin Hcl Er	Metformin Hcl	74	14
Allopurinol	Allopurinol	72	18
Eliquis	Apixaban	71	14
Albuterol Sulfate Hfa	Albuterol Sulfate	70	24
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	70	14
Rosuvastatin Calcium	Rosuvastatin Calcium	70	21
Celecoxib	Celecoxib	66	21
Meloxicam	Meloxicam	65	19
Ozempic	Semaglutide	63	12
Venlafaxine Hcl Er	Venlafaxine Hcl	59	suppressed
Citalopram Hbr	Citalopram Hydrobromide	57	18
Fluoxetine Hcl	Fluoxetine Hcl	55	13
Fluticasone Propionate	Fluticasone Propionate	52	15
Alprazolam	Alprazolam	51	12
Bupropion Xl	Bupropion Hcl	50	13
Quetiapine Fumarate	Quetiapine Fumarate	50	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	46	suppressed
Pravastatin Sodium	Pravastatin Sodium	46	13
Alendronate Sodium	Alendronate Sodium	45	15
Xarelto	Rivaroxaban	45	suppressed
Terazosin Hcl	Terazosin Hcl	44	suppressed
Carvedilol	Carvedilol	43	12
Zolpidem Tartrate	Zolpidem Tartrate	43	suppressed
Finasteride	Finasteride	41	suppressed
Propranolol Hcl	Propranolol Hcl	41	suppressed
Atenolol	Atenolol	40	11
Chlorthalidone	Chlorthalidone	40	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	40	11
Spironolactone	Spironolactone	39	12
Methocarbamol	Methocarbamol	38	14
Warfarin Sodium	Warfarin Sodium	38	suppressed
Ventolin Hfa	Albuterol Sulfate	36	16
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	35	11
Pregabalin	Pregabalin	34	suppressed
Valacyclovir	Valacyclovir Hcl	33	suppressed
Baclofen	Baclofen	32	suppressed
Oxycodone Hcl	Oxycodone Hcl	32	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	32	suppressed
Clonazepam	Clonazepam	31	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	31	suppressed
Jardiance	Empagliflozin	31	suppressed
Symbicort	Budesonide/Formoterol Fumarate	31	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	30	13
Donepezil Hcl	Donepezil Hcl	29	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	29	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	27	suppressed
Paroxetine Hcl	Paroxetine Hcl	27	suppressed
Clopidogrel	Clopidogrel Bisulfate	26	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	26	suppressed
Gemfibrozil	Gemfibrozil	25	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	25	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	24	suppressed
Temazepam	Temazepam	24	suppressed
Mounjaro	Tirzepatide	23	suppressed
Benazepril Hcl	Benazepril Hcl	22	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	22	suppressed
Synthroid	Levothyroxine Sodium	22	suppressed
Ezetimibe	Ezetimibe	21	suppressed
Ibuprofen	Ibuprofen	21	suppressed
Ropinirole Hcl	Ropinirole Hcl	21	suppressed
Divalproex Sodium	Divalproex Sodium	20	suppressed
Lorazepam	Lorazepam	20	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	19	suppressed
Estradiol	Estradiol	19	suppressed
Irbesartan	Irbesartan	18	suppressed
Prednisone	Prednisone	18	16
Tizanidine Hcl	Tizanidine Hcl	18	suppressed
Myrbetriq	Mirabegron	17	suppressed
Amoxicillin	Amoxicillin	16	suppressed
Buspirone Hcl	Buspirone Hcl	16	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	15	suppressed
Acyclovir	Acyclovir	14	suppressed
Aripiprazole	Aripiprazole	14	suppressed
Breo Ellipta	Fluticasone/Vilanterol	14	suppressed
Cephalexin	Cephalexin	14	12
Diltiazem 24hr Er	Diltiazem Hcl	14	suppressed
Divalproex Sodium Er	Divalproex Sodium	14	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	14	13
Lubiprostone	Lubiprostone	14	suppressed
Mupirocin	Mupirocin	14	suppressed
Promethazine Hcl	Promethazine Hcl	14	suppressed
Spiriva Handihaler	Tiotropium Bromide	14	suppressed
Diazepam	Diazepam	13	suppressed
Lovastatin	Lovastatin	13	suppressed
Naltrexone Hcl	Naltrexone Hcl	13	suppressed
Ondansetron Odt	Ondansetron	13	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	12	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	12	suppressed
Memantine Hcl Er	Memantine Hcl	12	suppressed
Bevespi Aerosphere	Glycopyrrolate/Formoterol Fum	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	11	suppressed
Ipratropium Bromide	Ipratropium Bromide	11	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	11	suppressed
Nystatin	Nystatin	11	suppressed
Progesterone	Progesterone, Micronized	11	suppressed
Tradjenta	Linagliptin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error